Delivery Order SPE2DR25D3002-SPE2DR26FVXZ0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $7,755.83. This firm fixed price delivery order, with an ultimate completion date of December 17, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $7,593.63. This firm fixed-price delivery order, with an ultimate completion date of December 18, 2025, represents a small-value pharmaceutical procurement under the company's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $9,160.81. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,277.90 to AmerisourceBergen Drug Corp for the supply of Malarone 250/100 (100 tablets), a pharmaceutical product used for malaria prevention and treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) valued at $1,363.98. This firm fixed-price delivery order, which is a child contract under a larger vehicle, has an ultimate completion date of September 18, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) at a contract ceiling value of $1,818.64. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a competitive award with no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for Malarone 250/100 tablets (100 count) valued at $13,434.32 under a firm fixed price arrangement. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and deliver the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $4,303.64. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $8,408.92 for 100 tablets of Malarone 250/100, an antimalarial medication. The order, issued on November 3, 2025, with an ultimate completion date of December 2, 2025, represents a firm fixed-price transaction with no set-aside designation. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Malarone 250-100 mg tablets in a quantity of 100 units, valued at $1,363.98. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D3002Indefinite Delivery Contract
- SPE2DR25D3002-SPE2DR26FVXZ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $19,740.07. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical's comprehensive global pharmaceutical support vehicle, the company supplies an extensive portfolio of pharmaceuticals and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers. This delivery order for antimalarial medication exemplifies the routine pharmaceutical procurement operations conducted through the company's established IDC framework, which enables flexible fulfillment of federal medical supply needs across global military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 12/16/25 |